市场调查报告书
商品编码
1359549
颅内狭窄支架市场规模 - 按类型、最终用途 - 2023-2032 年全球预测Intracranial Stenosis Stents Market Size - By Type, By End-use - Global Forecast 2023-2032 |
由于老年人口基数不断扩大,2023 年至 2032 年间,全球颅内狭窄支架市场规模将呈现 5.1% 的复合年增长率。据世界卫生组织称,从2015年到2050年,全球60岁及以上人口预计将增加近一倍,从12%增加到22%。此外,预计在此期间 80% 的老年人将居住在中低收入国家。
随着老年人口的增长,包括颅内狭窄在内的脑血管疾病的盛行率可能会增加。对用于管理和治疗这些疾病的支架的需求预计将会增加,从而推动市场扩张。此外,医疗技术的进步以及对改善老年人医疗保健结果的日益关注将进一步增强市场前景。
整个颅内狭窄支架市场根据类型、最终用途和地区进行分类。
由于治疗特发性颅内高压和静脉窦狭窄等疾病的需求不断增加,静脉窦支架产业将从 2023 年到 2032 年以显着的复合年增长率扩张。这些支架提供了一种微创解决方案,可恢復大脑静脉窦的正常血流。这有助于降低颅内压并减轻相关症状,使其成为患有这些疾病的患者的重要医疗干预措施。
由于ASC对微创支架的需求不断增加,到2032年,门诊手术中心细分市场将累积相当大的颅内狭窄支架市场份额。这些支架能够有效治疗脑血管疾病,缩短患者復原时间并缩短住院时间。门诊手术中心的便利性和效率使其成为涉及颅内狭窄支架手术的首选,进一步推动了此类手术的需求。
由于脑血管疾病发生率的增加和人口老化的加剧,欧洲颅内狭窄支架产业将在 2032 年之前获得可观的成长。此外,医疗技术的进步和该地区完善的医疗基础设施正在推动基于支架的治疗的采用。这些因素,加上人们对脑血管疾病的认识不断提高,正在促进该行业在欧洲的成长。
Global Intracranial Stenosis Stents Market size will exhibit 5.1% CAGR between 2023 and 2032, attributed to the expanding geriatric population base. According to WHO, from 2015 to 2050, the global population aged 60 and above is expected to nearly double, increasing from 12% to 22%. Furthermore, it's projected that 80% of older individuals will reside in nations with lower and middle-income levels during this period.
As the elderly demographic grows, the prevalence of cerebrovascular conditions, including intracranial stenosis, could increase. The demand for stents to manage and treat these conditions is expected to rise, driving market expansion. Moreover, advancements in medical technology and an increasing focus on improving healthcare outcomes among aging people will further strengthen the market outlook.
The overall Intracranial Stenosis Stents Market is categorized based on type, end-use, and region.
The venous sinus stents industry will expand at a noteworthy CAGR from 2023 to 2032, driven by the escalating need to treat conditions like idiopathic intracranial hypertension and venous sinus stenosis. These stents provide a minimally invasive solution to restore proper blood flow in the brain's venous sinuses. This helps reduce intracranial pressure and alleviate related symptoms, making them a crucial medical intervention for patients with these conditions.
The ambulatory surgical centers segment will accumulate a decent intracranial stenosis stents market share by 2032 due to the increasing demand for minimally invasive stents across ASCs. These stents enable effective treatment of cerebrovascular conditions with reduced patient recovery time and shorter hospital stays. The convenience and efficiency of ambulatory surgical centers make them a preferred choice for procedures involving intracranial stenosis stents, further driving their demand in this setting.
Europe Intracranial Stenosis Stents Industry will garner appreciable gains through 2032 due to increasing incidences of cerebrovascular diseases and a growing aging population. Moreover, advancements in medical technology and the region's well-established healthcare infrastructure are driving the adoption of stent-based treatments. These factors, combined with a rising awareness of cerebrovascular conditions, are contributing to the industry's growth in Europe.